Identification of a gene element essential for leukemia-specific expression of transgenes

Leukemia

Volumn 18, Issue 3, 2004, Pages 415-419

  Hosen, N ^a   Yanagihara, M ^a   Nakazawa, T ^a   Kanato, K ^a   Nishida, S ^a   Shirakata, T ^a   Asada, M ^a   Masuda, T ^a   Taniguchi, Y ^a   Kawakami, M ^a   Tsuboi, A ^a   Ikegame, K ^a   Oka, Y ^a   Ogawa, H ^a   Kawase, I ^a   Oji, Y ^a   Sugiyama, H ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Enhancer; Gene therapy; Green fluorescent protein (GFP); Promoter; WT1

Indexed keywords

GREEN FLUORESCENT PROTEIN; WT1 PROTEIN; PHOTOPROTEIN;

3' UNTRANSLATED REGION; ARTICLE; CELL STRAIN K 562; CELL STRAIN U937; COLON CANCER; CONTROLLED STUDY; DAUDI CELL; ENHANCER REGION; GENE ACTIVITY; GENE EXPRESSION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE TARGETING; GENE THERAPY; GENE VECTOR; GENETIC TRANSFECTION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; INTRON; KIDNEY CELL CULTURE; LEUKEMIA CELL; LEUKEMIA CELL LINE; NEPHROBLASTOMA; NUCLEOTIDE SEQUENCE; OVARY CELL CULTURE; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SUICIDE GENE THERAPY; TRANSGENE; CELL CULTURE; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; GENETICS; METABOLISM; METHODOLOGY; NEOPLASM; PHYSIOLOGY;

ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; LUMINESCENT PROTEINS; NEOPLASMS; TRANSDUCTION, GENETIC; TRANSGENES; TUMOR CELLS, CULTURED; WT1 PROTEINS;

EID: 1542503853     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403260     Document Type: Article

References (34)

1. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome Wilms tumor locus. Cell 1990; 60: 509-520.
2. Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GA. Homozygous deletion in Wilms tumors of a zinc-finger gene identified by chromosome jumping. Nature 1990; 343: 774-778.
3. Menke AL, Van der Eb AJ, Jochemsen AG. The Wilms'tumor gene: Oncogene or tumor suppressor gene? Int Rev Cytol 1998; 181: 151-212.
4. Buckler AJ, Pelletier J, Haber DA, Glaser T, Housman DE. Isolation characterization expression of the murine Wilm's tumor gene (WT1) during kidney development. Mol Cell Biol 1991; 11: 1707-1712.
5. Park S, Schalling M, Bernard A, Maheswaran S, Shipley GC, Roberts D et al. The Wilms tumor gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma. Nature Genet 1993; 4: 415-420.
6. Pritchard-Jones K, Renshaw J, King-Underwood L. The Wilms' tumor (WT1) gene is mutated in a secondary leukemia in WAGR patient. Hum Mol Genet 1994; 3: 1633-1637.
7. Fraizer GC, Patmasiriwat P, Zhang X, Saunders GF. Expression of the tumor suppressor gene WT1 in both human and mouse bone marrow. Blood 1995; 86: 4704-4706.
8. Baird PN, Simmons PJ. Expression of the Wilms'tumor gene (WT1) in normal hematopoiesis. Exp Hematol 1997; 25: 312-320.
9. Inoue K, Ogawa H, Sonoda Y, Kimura T, Sakabe H, Oka Y et al. Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia. Blood 1997; 89: 1405-1412.
10. + progenitors. Blood 1997; 90: 4230-4232.
11. + hematopoietic progenitors during fetal development and early clonogenic growth. Blood 1997; 89: 3486-3487.
12. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R. WT-1 is required for early kidney development. Cell 1993; 74: 679-691.
13. Inoue K, Sugiyama H, Ogawa H, Nakagawa M, Yamagami T, Miwa H et al. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood 1994; 84: 3071-3079.
14. Menssen HD, Renkl HJ, Rodeck U, Mauer J, Notter M, Schwartz S et al. Presence of Wilms' tumor gene (wt1) transcripts and WT1 nuclear protein in the majority of human acute leukemia. Leukemia 1995; 9: 1060-1067.
15. Miwa H, Beran M, Saunders GF. Expression of the Wilms' tumor gene (WT1) in human leukemias. Leukemia 1992; 6: 405-409.
16. Miyagi T, Ahuja H, Kubota T, Kubonishi I, Koeffler HP, Miyoshi I. Expression of the candidate Wilm's tumor gene WT-1, in human leukemia cells. Leukemia 1993; 7: 970-977.
17. Hosen N, Sonoda Y, Oji Y, Kimura T, Minamiguchi H, Tamaki H et al. Very low frequencies of human normal CD34+ haematopoietic progenitor cells express the Wilms' tumour gene WT1 at levels similar to those in leukaemia cells. Br J Haematol 2002; 116: 409-420.
18. Oka Y, Udaka K, Tsuboi A, Elisseeva OA, Ogawa H, Aozasa K, Kishimoto T, Sugiyama H. Cancer immunotherapy targeting Wilms' tumor gene WT1 product. J Immunol 2000; 164: 1873-1880.
19. Ohminami H, Yasukawa M, Fujita S. HLA class I-restricted lysis of leukemia cells by a CD8(+) cytotoxic T-lymphocyte clone specific for WT1 peptide. Blood 2000; 95: 286-293.
20. Gao L, Bellantuono I, Elsasser A, Marley SB, Gordon MY, Goldman JM et al. Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1. Blood 2000; 95: 2198-2203.
21. Gaiger A, Reese V, Disis ML, Cheever MA. Immunity to WT1 in the animal model and in patients with acute myeloid leukemia. Blood 2000; 96: 1480-1489.
22. Miller N, Whelan J. Progress in transcriptionally targeted and regulatable vectors for genetic therapy. Hum Gene Ther 1997; 8: 803-815.
23. Fraizer GC, Wu Y, Hewitt SM, Maity T, Ton CT, Huff V et al. Transcriptional regulation of the human Wilms' tumor gene (WT1). J Biol Chem 1994; 269: 8892-8900.
24. Zhang X, Xing G, Fraizer GC, Saunders GF. Transactivation of an intronic hematopoietic-specific enhancer of the human Wilms' tumor 1 gene by GATA-1 and c-Myb. J Biol Chem 1997; 272: 29272-29280.
25. Yoshiya N. Establishment of a cell line from human ovarian cancer (undifferentiated carcinoma of FIGO classification) and analysis of its cell-biological characteristics and sensitivity to anticancer drugs. Acta Obstet Gynaecol Jpn 1986; 38: 1747-1753.
26. Leibovitz A, Stinson JC, McCombs III WB, McCoy CE, Mazur KC, Mabry ND. Classification of human colorectal adenocarcinoma cell lines. Cancer Res 1976; 36: 4562-4569.
27. Alberrta JA, Springett GM, Raybum H, Natoli TA, Loring J, Kreidberg JA et al. Role of the WT1 tumor suppressor in murine hematopoiesis. Blood 2003; 1011: 2570-2574.
28. Mundlos S, Pelletier J, Darveau A, Bachmann M, Winterpacht A, Zabel B. Nuclear localization of the protein encoded by the Wilms' tumor gene WT1 in embryonic and adult tissues. Development 1993; 119: 1329-1341.
29. Oji Y, Yamamoto H, Nomura M, Nakano Y, Ikeba A, Nakatsuka S, Abeno S et al. Overexpression of the Wilms' tumor gene WT1 in colorectal adenocarcinoma. Cancer Sci 2003; 94: 712-717.
30. Wilcox DA, Olsen JC, Ishizawa L, Griffith M, White II GC. Integrin állb promoter-targeted expression of gene products in megakaryocytes derived from retrovirus-transduced human hematopoietic cells. Proc Natl Acad Sci USA 1999; 96: 9654-9659.
31. Ido A, Nakata K, Kato Y, Nakao K, Murata K, Fujita M et al. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human á-fetoprotein gene promoter. Cancer Res 1995; 55: 3105-3109.
32. Braiden V, Nagayama Y, Iitaka M, Namba H, Niwa M, Yamashita S. Retrovirus-mediated suicide gene/prodrug therapy targeting thyroid carcinoma using a thyroid-specific promoter. Endocrinology 1998; 139: 3996-3999.
33. Moreau-Gaudry F, Xia P, Jiang G, Perelman NP, Bauer G, Ellis J et al. High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors. Blood 2001; 98: 2664-2672.
34. Marodon G, Mouly E, Blair EJ, Frisen C, Lemoine FM, Klatzmann D. Specific transgene expression in human and mouse CD4+ cells using lentiviral vectors with regulatory sequences from the CD4 gene. Blood 2003; 101: 3416-3423.